MAPT and Alzheimer disease: Since GSK-3 is a well-established tau kinase, and tau is abnormally phosphorylated in AD, we next investigated whether the protective effect of Sgg inhibition on Aβ42 toxicity in our fly model is mediated via alterations in tau phosphorylation.